BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly ...
Maan Alkaisi, whose wife was one of 115 people killed in the preventable collapse in 2011, addressed the families of the 16 ...
RAPT Therapeutics, Inc. ( NASDAQ: RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria October 20, 2025 8:30 AM EDT Good morning, and welcome to RAPT's conference ...
One major reason that might have informed the choice of the theme of the 46th Annual Conference of the Nigerian Society of International Law, holding on Tuesday, 21st and Wednesday, 22nd October, 2025 ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
The ADB report highlights how digital innovations—like apps, chatbots, and multilingual reporting systems—are transforming ...
Adverse events (AEs) generally transient and readily manageable; only 2 cases of cytokine release syndrome (CRS)Prolonged tumor control with ...